AR128777A1 - Vacuna viva contra mycoplasma synoviae - Google Patents

Vacuna viva contra mycoplasma synoviae

Info

Publication number
AR128777A1
AR128777A1 ARP230100621A ARP230100621A AR128777A1 AR 128777 A1 AR128777 A1 AR 128777A1 AR P230100621 A ARP230100621 A AR P230100621A AR P230100621 A ARP230100621 A AR P230100621A AR 128777 A1 AR128777 A1 AR 128777A1
Authority
AR
Argentina
Prior art keywords
mycoplasma synoviae
vaccine against
live vaccine
against mycoplasma
birds
Prior art date
Application number
ARP230100621A
Other languages
English (en)
Spanish (es)
Inventor
Naola M Ferguson-Noel
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Publication of AR128777A1 publication Critical patent/AR128777A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP230100621A 2022-03-14 2023-03-14 Vacuna viva contra mycoplasma synoviae AR128777A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263319532P 2022-03-14 2022-03-14

Publications (1)

Publication Number Publication Date
AR128777A1 true AR128777A1 (es) 2024-06-12

Family

ID=88024180

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100621A AR128777A1 (es) 2022-03-14 2023-03-14 Vacuna viva contra mycoplasma synoviae

Country Status (8)

Country Link
US (1) US20250186512A1 (https=)
EP (1) EP4493202A1 (https=)
JP (1) JP2025509627A (https=)
CN (1) CN118891358A (https=)
AR (1) AR128777A1 (https=)
AU (1) AU2023235062A1 (https=)
MX (1) MX2024011062A (https=)
WO (1) WO2023177620A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens
CN112779193B (zh) * 2021-02-24 2022-09-27 福建省农业科学院畜牧兽医研究所 一株滑液囊支原体强毒株及其应用

Also Published As

Publication number Publication date
MX2024011062A (es) 2024-09-23
US20250186512A1 (en) 2025-06-12
WO2023177620A9 (en) 2024-05-10
JP2025509627A (ja) 2025-04-11
CN118891358A (zh) 2024-11-01
EP4493202A1 (en) 2025-01-22
AU2023235062A1 (en) 2024-09-19
WO2023177620A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
MX2024011270A (es) Vacunas vivas contra mycoplasma gallisepticum.
NI202000040A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos
CO6270337A2 (es) Vacuna viva avirulenta de mycoplama hyopneumoniae con adyuvante
UY38982A (es) Composiciones farmacéuticas
DOP2017000175A (es) Dinucleótidos cíclicos útiles en el tratamiento del cáncer
PH12021552944A1 (en) A formulation of a conjugate of a tubulysin analog to a cell-binding molecule
MX393782B (es) Formulaciones a largo plazo
CO2019000214A2 (es) Vacuna contra virus de bronquitis infecciosa
AR106026A1 (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos
BR112023000220A2 (pt) Formulações de longa ação
MX2017009306A (es) Vacuna contra la fiebre aftosa.
CL2021002582A1 (es) Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos
BR112021024651A2 (pt) Composição farmacêutica parenteral isotônica, método para melhoria da estabilidade química da dita composição e uso de manitol ou um sal
AR104173A1 (es) Variantes de protoxina ii y métodos de uso
CO6280408A2 (es) Vacuna de virus de la lengua azul y composiciones inmunogenicas procedimientos de uso y procedimeintos de la produccuion de la misma
BR112023005001A2 (pt) Isolado atenuado do vírus da estirpe dmv1639 de bronquite infecciosa
AR128777A1 (es) Vacuna viva contra mycoplasma synoviae
MX2021012201A (es) Adyuvante soluble en agua.
MX2023010231A (es) Extractos de colageno para su uso como medicamento.
MX2022010781A (es) Vacuna contra el virus sars-cov-2 con adyuvante cpg.
MX2022012447A (es) Vacuna inactivada contra el virus sars-cov-2.
MX382396B (es) Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales.
AR128986A1 (es) Vacuna viva contra mycoplasma gallisepticum
RU2013122510A (ru) Стоматологический гель с ниосомами для лечения воспалительных и дистрофических заболеваний пародонта
MX2022010201A (es) Uso de analogos de ciclosporina para el tratamiento de la fibrosis.